Exxaro Tiles Ltd IPO: Apply or Not?

On January 2, 2008, 'Ricasil Ceramic Pvt Ltd' was incorporated in Himmatnagar as' Ricasil Ceramic Pvt Ltd. ' On December 9, 2020, a General Meeting was conducted. The company's name was changed to its current name, 'Exxaro Tiles Limited.'

Production Specifications: Double Charge Verified Tiles and Glazed Vitrified Tiles are produced by the business. At the moment, the company primarily offers products in 6 sizes and 1000+ designs. Exxaro Tiles Ltd. has two cutting-edge production plants in Gujarat, Padra and Talod, with a combined installation capacity of 1,32,00,000 sq. mt. p.a. Unit II is one of the largest plants for manufacturing glazed verified tiles under one roof in India. (Source: Brickwork Report) 

Network of the Company: Currently, over 2000 registered dealers supply products for large-scale infrastructure projects. The company has grown its operations to 27 states and 12 countries, including Poland, Italy, and Bosnia.

Revenue from Exports: For fiscal years 2021, 2020, and 2019, the company's revenue from exports contributed 13.88%, 13.51%, and 6.68%, respectively, of all its revenue operations.

Strengths of the Company:

1. Modern production facilities with a significant emphasis on design and quality.
2. Widespread sales and dealers network
3. A large product portfolio with around 1000 designs

Financials of The Company:

Particulars	for the year/period ended (₹ in million)
	31-03-2021	31-03-2020	31-03-2019
Total Assets	3693.14	3870.55	3582.55
Total Revenue	2598.53	2439.64	2440.06
Profit After Tax	152.23	112.59	89.17

IPO Details:

IPO Opening Date	04-08-2021
IPO Closing Date	06-08-2021
Face Value	10₹. Per Equity Share
or the year/period ended (₹ in million)IPO Price	₹118 to ₹120 per equity share
Market Lot	125 Shares
Listing At	BSE, NSE
Issue Size	161.09 Cr.

IPO Time Table:

IPO Open Date	04-08-2021
IPO Close Date	06-08-2021
Allotment Date	11-08-2021
Listing Date	17-08-2021

Recommendation

Apply for only listing gain

(Source:- All details are collected from sebi website)

Should we apply for Devyani International IPO? - check this.

Devyani International Limited is the largest   franchisee of Yum Brands in India.   Founded  in 1991, they are among the   largest operators of chain quick-service     restaurants in India. The company operates   665 stores across 155cities in India, as of   March 31, 2021.

 Overview of the Company

Devyani International Limited first   collaborated with Yum in 1997, when it opened a Pizza Hut location in Jaipur. Following that, they extended their business by acquiring KFC and Pizza Hut franchisees. As of March 31, 2021, the business operated 264 KFC restaurants, 297 Pizza Hut restaurants, and 44 Costa Coffee locations throughout India.

The company's operations are divided into three business verticals.

1. KFC, Pizza Hut, and Costa Coffee are examples of core brands.

2. International expansion — KFC and Pizza Hut locations in Nepal and Nigeria.

3. Other businesses — Own-brand stores such as Vaango and Food Street in the F & B industry.

Strengths of the Company

1. A portfolio of well-known worldwide brands.

2. A multi-dimensional, all-inclusive QSR player.

3. Presence in major consuming markets using a cluster-based strategy.

4. Cross-brand synergies through operational leverage.

5. A distinguished Board of Directors and an experienced senior management team.

Strategy of the Company

1. Continue to improve unit-level performance by strategically expanding the Brand Business retail network.

2. Invest in technology and emphasize digital capabilities.

Company Financial

Particulars	For the Year ended (Rs. In a million)
	31-03-2021	31-03-2020	31-03-2019
Total Assets	16684.07	18835.76	18074.90
Total Revenue	11988.95	15350.41	13236.83
Profit After Tax	-813.24	-787.52	-592.90

IPO Details

Ipo Opening Date	04-08-2021
Ipo Closing Date	06-08-2021
IPO Price	Rs. 86 to Rs.90 per Equity Share
Market Lot	165 Shares
Issue Size	Equity Share of Rs.1 (aggregating up to Rs.1838.00 Cr)

IPO Time Table

Opening Date	04-08-2021
Closing Date	06-08-2021
Allotment Date	11-08-2021
Listing Date	16-08-2021

I do not recommend this IPO because the company has been making losses for a long time.

Windlas Biotech Limited - IPO details

The company was incorporated as 'Windlas Biotech Limited' on February 19, 2001. The Company is one of the leading in the domestic pharmaceutical formulations contract development and manufacturing organization (CDMO) industry in India in terms of revenue. With over two decades of experience in manufacturing both solid and liquid pharmaceutical dosage form and significant experience in providing specialized capabilities, including, high potency, controlled substances and low-solubilify. Windlas Biotech provides a comprehensive range of  CDMO services ranging from product discovery, product development, licensing and commercial manufacturing of generic products, including complex generics.

Market Share:- In 2020 Windlas Biotech Limited's market share was approximately 1.5% in terms of revenue in the domestic formulations CDMO industry.

Sales Process:- The company also sell their own branded products in the trade generics and OTC market as well as export generic products to several countries.  

Current Focus:- Windlas Biotech Limited currently focus on launching new complex generic products in chronic therapeutic category linked in to lifestyle related disorders.

Business Verticals:- The Company has three distinct strategic business verticals.

1. CDMO Service and Products
2. Domestic Trade Generics and over-the-counter Brands
3. Exports

All verticals are supported by a network of R&D laboratories and manufacturing facilities which in turn are supported by various functions, including supply chain, inventory, finance and human resources.

Company Strengths:-

1. Leading CDMO in India with a focus on the chronic therapeutic category.
2. Innovative Portfolio of complex generic products supported by robust R&D Capabilities.
3. Efficient and quality compliant manufacturing facilities with significant entry barriers.
4. Strong and long-term relationships with leading Indian pharmaceutical Companies
5. Consistent track record of financial performance
6. Experienced Professional and Technical Qualified Management Team

Financial Reports:-

Particulars	Years (amt in Millions)
	31-12-2020	31-03-2020	31-03-2019
Total Assets	3158.83	3384.88	2981.80
Total Revenue	3230.94	3313.39	3565.76
Profit After Tax	96.74	162.13	638.22

 

IPO Details:-

IPO Opening Date	4/08/2021
IPO Closing Date	06/08/2021
Face Value	5 Rs. Per Equity Share
IPO Price	Rs. 448 to Rs.460 per Share
Market Lot	30 Shares
Listing At	BSE, NSE
Issue Size	401.54 Cr

IPO Table:-

IPO Open Date	04/08/2021
IPO Close Date	06/08/2021
Allotment Date	11/08/2021
Listing Date	17/08/2021

  

IPO Lot Size:-

minimum 1 lot (30 shares, amt 13800 Rs.) maximum 14 lots (420 Shares, amt 193200Rs.)

Our Suggestion 

Recommended for short term

Rolex Rolled Rings IPO Details with Grey Market Premium.

 Company History:-

Rolex Rolled Rings started as a partnership in 1977-78 under the name Rolex Industries, and was later converted into a joint stock company under the Companies Act 1951, with the name Rolex Rings Pvt Ltd and a certificate of incorporation dated February 13, 2003.

Business Overview:-

The company produces hot rolled forged and machine bearing rings, as well as automotive components for vehicle segments such as two-wheelers, passenger vehicles, commercial vehicles, off-highway vehicles, electric vehicles, industrial machines, wind turbines, and railways. The Company domestically and internationally to large marquee customers, including some leading bearing manufacturing companies. The Company has 22 forging lines with a combined installed capacity of 1,44,750 M.T.P.A., Machining facility with 528 spindles and a total install capacity of 69 million components per year.

Company Strength:-

1. One of the Top 5 Forging Company.
2. Strong Manufacturing Capacity
3. Good business background History.
4. Export in 19 Countries since long time with healthy relation
5. Continue financial growth

Financial Details of Company:-

Particulars	Years     (amt in a million)
	31-03-2021	31-03-2020	31-03-2019
Total Assets	7969.24	6861.73	7822.57
Total Revenue	6197.57	6753.32	9112.54
Profit After Tax	869.55	529.41	590.51

 IPO Details:-                                                                  

IPO Opening Date	28-07-2021
IPO Closing Date	30-07-2021
Face Value	10 Rs. Per Equity Share
IPO Price	880 Rs. To 990 Rs.
Market Lot	16 Shares
Listing At	BSE, NSE
Issue Size	731 CR.

IPO Time Table:-

IPO Open Date	28-07-2021
IPO Close Date	30-07-2021
Allotment Date	04-08-2021
Listing Date	09-08-2021

IPO Lot Size:

minimum lot size 1 (16 shares =14400Rs.) & maximum lot size 13 (208 shares = 187200Rs.)

Grey Market Premium:-

Grey market premium as on 27-07-2021 is 450 Rs. per share.

Our Suggestion:-

Recommended.

IPO: Glenmark Life Sciences.

COMPANY HISTORY

Glenmark Life Sciences (GLS) is founded in 2011. The company is a leading developer and manufacturer of Active Pharmaceutical Ingredients. GLS partners with the world's 16 of the top 20 generic companies & serves customers in multiple geographies including North America, Europe, Japan, Latin America and ROW.

Financials of The Company

Particulars	Years (amt in lakh)
	31/03/2021	31/03/2020	31/03/2019
Total Assets	19970.75	17256.04	14753.95
Total Revenue	18859.76	15493.03	8868.65
Profit After Tax	3515.81	3130.98	1955.92

Promoters' Holding:

After successful listing, promotors' Holding will be reduced form 100% to 82.84%.

IPO Details

IPO Opening Date	27-07-2021
IPO Closing Date	29-07-2021
IPO PRICE	Rs.695 to Rs.720 per equity share
Minimum Lot Size	20 Shares (1Lot)
Maximum Lot Size	260 Shares (13Lots)
Minimum Investment Amount	14400
Maximum Investment Amount	187200
Listing At	BSE, NSE
Issue Size	Equity Shares of Rs.2 (aggregating up to Rs.1513.6 Cr)
IPO Listing Date	06-08-2021

Grey Market Premium

GLS IPO grey market premium today is Rs.210.

My Recommendation

Every one should apply for this IPO.